Showing results (151-160 of 250) with videos related to
Sort By:
Pageof 25
The Journal of Experimental Medicine|July 16, 2008
Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individualsSusan Moir, Jason Ho, Angela Malaspina, et al.The Journal of Infectious Diseases|March 7, 2019
Impact of Treatment Interruption on HIV Reservoirs and Lymphocyte Subsets in Individuals Who Initiated Antiretroviral Therapy During the Early Phase of InfectionErin D Huiting, Kathleen Gittens, J Shawn Justement, et al.The Journal of Infectious Diseases|April 29, 2016
Maintenance of HIV-Specific Memory B-Cell Responses in Elite Controllers Despite Low Viral BurdensClarisa M Buckner, Lela Kardava, Xiaozhen Zhang, et al.AIDS (London, England)|December 16, 2010
Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individualsJason Ho, Susan Moir, Wei Wang, et al.AIDS (London, England)|October 22, 2010
Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradicationTae-Wook Chun, J Shawn Justement, Danielle Murray, et al.The Journal of Infectious Diseases|May 23, 2014
HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatmentKatherine Luzuriaga, Barbara Tabak, Manuel Garber, et al.The Journal of Infectious Diseases|February 5, 2008
Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV diseaseSusan Moir, Angela Malaspina, Jason Ho, et al.The Journal of Infectious Diseases|April 6, 2023
Impact of Monkeypox Virus Infection on Immune Parameters in a Woman With Human Immunodeficiency Virus Receiving Clinically Effective Antiretroviral TherapyM Ali Rai, Victoria Shi, Brooke D Kennedy, et al.Proceedings of the National Academy of Sciences of the United States of America|May 6, 2003
Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individualsSusan Moir, Kisani M Ogwaro, Angela Malaspina, et al.Proceedings of the National Academy of Sciences of the United States of America|May 7, 2020
Prodrugs of PKC modulators show enhanced HIV latency reversal and an expanded therapeutic windowJack L Sloane, Nancy L Benner, Katherine N Keenan, et al.Pageof 25